AHCCCS Pharmacy Information
Subscribe to receive email alerts
Updated Synagis Coverage 2022-2023
Human Respiratory Syncytial Virus (RSV) causes respiratory tract infections and serious lung disease in infants and children. Synagis (palivizumab) is available for children that are at high risk for RSV. Please view the link below for information regarding the 2022/2023 Synagis coverage
The AHCCCS Pharmacy & Therapeutics Committee (Committee) is advisory to the AHCCCS Administration and is responsible for evaluating scientific evidence of the relative safety, efficacy, effectiveness and clinical appropriateness of prescription drugs. The Committee makes recommendations to the AHCCCS Administration on the development and maintenance of a statewide drug list and prior authorization criteria as appropriate. The Committee may also evaluate individual drugs and therapeutic classes of drugs.
The meetings are open to the public.
P&T Meeting Public Testimony, for persons that are not representing a pharmaceutical company, pharmacy benefit manager or related entity, may be given orally or submitted as a written document in accordance with the AHCCCS P&T Operational Policy
Each person must fill out the Public Testimony Registration Form and the Conflict of Interest Form to register for the meeting. See the AHCCCS P&T Operational Policy for deadlines.
Provider Synergies, LLC is an affiliate of Magellan Medicaid Administration contracted with AHCCCS to facilitate and collect rebates for the supplemental rebate program. For up to date information regarding therapeutic class reviews and public testimony registration, please visit the Provider Synergies Website.
P&T Application - Now Accepting New Members
The AHCCCS Pharmacy and Therapeutics Committee is now accepting new members for the following positions:
- Health Care Providers - 3 Representatives
- Public - 2 Representatives (Inter-Tribal Council of Arizona and Medicaid Member)
- AHCCCS MCO's and TRBHA - 2 Representatives (TRBHA Pharmacy Director and/or TRBHA Medical Director)
- University Representative - 1 Representative (Researcher)
Please fill out the P&T Application and send to the Arizona Pharmacy Department ( AHCCCSPharmacyDept@azahcccs.gov ) for consideration.
P&T Meeting and Class Review Schedule
January 24, 2024
- Non-Supplemental Rebate Classes Review:
- Antidepressants - Other
- Antidepressants - SSRIs
- Beta Agonist Bronchodilators
- Bone Resorption Suppression and Related Agents
- Colony Stimulating Factors
- Enzyme Replacement - Gauchers Disease
- Erythropoiesis Stimulating Proteins
- Hypoglycemics - Alpha-Glucosidase Inhibitors
- Hypoglycemics - Metformins
- Hypoglycemics - SGLT2s
- Immune Globulins
- Oncology, Oral - Hematologic
- Ophthalmics – Anti-Inflammatory/Immunomodulators
- Otic Antibiotics
- PAH Agents - Oral and Inhaled
- Thrombopoiesis Stimulating Proteins
May 21, 2024
- Supplemental Rebate Classes Review:
- Inhaled Glucocorticoids
- Opiate Dependence Treatments
- Hypoglycemics - Incretin Mimetics/Enhancers
- Hypoglycemics -Insulin and Related Agents
- COPD Agents
- Antipsychotics - Oral 2nd Generation
- Antipsychotics - Atypical Long-Acting Injectables
- Stimulants and Related Agents
- Pancreatic Enzymes
- Anticoagulants
- Hepatitis C Agents
- Cytokine and CAM Antagonists
- Long Acting Narcotic Analgesics
- Growth Hormone
- Epinephrine, Self-Injected
- Antibiotics, Inhaled
- Antimigraine – CGRPs
- Glucagon
October 15, 2024
- Non-Supplemental Repeat Classes Review:
- Antimigraine Agents-Triptans
- Leukotriene Modifiers
- Phosphate Binders
- Sedative Hypnotics
- Topical Steroids by Potency (low, medium, high, very high)
- Antifungals-Oral
- Antifungals- Topicals
- Beta Blockers
- BPH Treatments
- Calcium Channel Blockers
- HIV-AIDS
- Movement Disorders
January 29, 2025
- Non-Supplemental Rebate Classes Review:
- Antidepressants - Other
- Antidepressants - SSRIs
- Beta Agonist Bronchodilators
- Bone Resorption Suppression and Related Agents
- Colony Stimulating Factors
- Enzyme Replacement - Gauchers Disease
- Erythropoiesis Stimulating Proteins
- Hypoglycemics - Alpha-Glucosidase Inhibitors
- Hypoglycemics - Metformins
- Hypoglycemics - SGLT2s
- Immune Globulins
- Oncology, Oral - Hematologic
- Ophthalmics – Anti-Inflammatory/Immunomodulators
- Otic Antibiotics
- PAH Agents - Oral and Inhaled
- Thrombopoiesis Stimulating Proteins
Agendas & Meeting Minutes
ANNOUNCEMENT: All AHCCCS P&T meetings will be held virtually until further notice.
October 25, 2023
- Meeting Documents
May 23, 2023
- Meeting Documents
January 25, 2023
October 19, 2022
- Meeting Documents
May 24, 2022
- Meeting Documents
January 19, 2022
October 18, 2021
- Meeting Registration
- Meeting Documents
May 19, 2021
- Meeting Documents
January 26, 2021
- Meeting Documents
- Agenda
- Public Testimony
- Angela Hughey
- Janice Piatt, MD
- Councilwoman Debra Stark
- Ravi Grivois-Shah, MD
- Sudha Nagalingam, MD
- Glen Spencer
- Southwest Center for HIV/AIDS
- Presentation
- AHCCCS Preferred Drug List Class Recommendations
- AHCCCS Preferred Drug Changes Effective April 1, 2021
- AHCCCS Preferred Drug Contractor's Notice Effective April 1, 2021
- Approved Meeting Minutes
Current P&T Committee Member Information
Prior Authorization Criteria
AIHP Drug Lists
- AHCCCS American Indian Health Plan Drug List - Effective October 1, 2023
- Over-the-Counter Drugs for Dual Eligibles (Effective January 1, 2021) | Rich Text Version
AIHP Pharmacy Information
Drug Prior Authorization Form
AHCCCS Policies and Changes
- Pharmacy And Therapeutics Committee Operational Policy
- Pharmacy and Therapeutics Committee Conflict of Interest Disclosure Form
- AHCCCS Medical Policy Manual Policy Exhibit 300-1 - Tobacco Cessation
- AHCCCS Medical Policy Manual Pharmacy Policy 310-V Prescription Medication / Pharmacy Services
- Fee-For-Service Provider Manual Pharmacy Chapter 12: Pharmacy Services
Regulatory Information
- 340B Rule
- Tamper Resistant Prescription Pads Memo 11/08/2012 | Rich Text Version & 04/27/2012 | Rich Text Version
- AHCCCS FFS and MCO Contractors BIN, PCN and Group ID's effective 4/1/23
- MCO Contractor Contact Information
- AHCCCS Pharmacy Email address: AHCCCSPHARMACYDEPT@AZAHCCCS.GOV
- Receive Update: Listserv Sign Up
For more information, you may contact the Pharmacy Department at AHCCCSPHARMACYDEPT@AZAHCCCS.GOV.
Archived pharmacy documents are available under ‘Pharmacy Updates’ in the AHCCCS Document Archive.